Affiliation: University of Maryland
- Trends in injection drug use among pregnant women admitted into drug treatment: 1994-2006Mishka Terplan
Department of Obstetrics, Gynecology and Reproductive Sciences, University of Maryland, Baltimore, Maryland, USA
J Womens Health (Larchmt) 19:499-505. 2010..To describe trends in the regional and demographic characteristics of injection drug use (IDU) during pregnancy...
- Have racial disparities in ovarian cancer increased over time? An analysis of SEER dataMishka Terplan
The University of Maryland School of Medicine, Department of Obstetrics, Baltimore, MD 21201, USA
Gynecol Oncol 125:19-24. 2012..We suspect that as improvements in treatment have evolved, the effects of access to treatment have amplified racial disparities in survival from ovarian cancer...
- Pregnant and non-pregnant women with substance use disorders: the gap between treatment need and receiptMishka Terplan
Department of Obstetrics, Gynecology and Reproductive Sciences, and Department of Epidemiology and Public Health, The University of Maryland School of Medicine, Baltimore, Maryland 21201, USA
J Addict Dis 31:342-9. 2012..92; 95% confidence interval (CI): 1.46, 2.52), however they were not more likely to receive treatment (OR = 0.90; 95% CI: 0.54, 1.51). Overall, there is an unmet need for treatment among reproductive-aged substance users...
- Naltrexone in the treatment of opioid-dependent pregnant women: the case for a considered and measured approach to researchHendree E Jones
RTI International, Research Triangle Park, NC 27709, USA
Addiction 108:233-47. 2013..Should future research be conducted, a multi-level commitment to proactive ethical research is needed to reach the ultimate goal of improving the lives of women and children affected by opioid dependence...
- Effect of waiting time on substance abuse treatment completion in pregnant womenJennifer Albrecht
Department of Epidemiology and Public Health, University of Maryland, Baltimore, MD 21201, USA
J Subst Abuse Treat 41:71-7. 2011..Waiting time impacts treatment completion in pregnant women. Resources need to be directed to ensure immediate access to treatment, particularly in the ambulatory setting...
- Human papillomavirus (HPV) vaccine uptake and completion at an urban hospitalNicholas H Schluterman
University of Maryland, School of Medicine, Department of Epidemiology and Public Health, 10 South Pine Street, MSTF 334F, Baltimore, MD 21201, United States
Vaccine 29:3767-72. 2011..Among those who initiate HPV vaccination, large proportions do not complete the three-dose regimen...
- "Compassionate coercion": factors associated with court-mandated drug and alcohol treatment in pregnancy 1994-2005Mishka Terplan
From the Department of Obstetrics and Gynecology MT, University of Maryland, Baltimore, MD Departments of Obstetrics and Gynecology EJS, MJK and Sociology MJK, School of Social Service Administration HAP, The University of Chicago, Chicago, IL
J Addict Med 4:147-52. 2010..To describe trends in court-mandated treatment in pregnancy. In particular, to determine whether pregnant women who enter treatment via the criminal justice system differ from women who enter voluntarily...